Clinical significance of surgical treatment for imatinib-resistant gastrointestinal stromal tumors.

被引：0
|
作者：
Hashimoto, Tadayoshi [1 ]
Takahashi, Tsuyoshi [1 ]
Kurokawa, Yukinori [1 ]
Kato, Ryo [1 ]
Wada, Noriko [1 ]
Tanaka, Koji [1 ]
Miyazaki, Yasuhiro [1 ]
Makino, Tomoki [1 ]
Yamasaki, Makoto [1 ]
Nakajima, Kiyokazu [1 ]
Mori, Masaki [1 ]
Doki, Yuichiro [1 ]
机构：
[1] Osaka Univ, Grad Sch Med, Osaka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
10.1200/JCO.2018.36.4_suppl.189
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
189
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Gastrointestinal stromal tumors.
    Blanke C.D.
    Eisenberg B.L.
    Heinrich M.C.
    Current Treatment Options in Oncology, 2001, 2 (6) : 485 - 491
  • [42] Analysis of genomic imbalances in imatinib-resistant, progressive gastrointestinal stromal tumors by array comparative genomic hybridization (aCGH)
    Wozniak, Agnieszka
    Rutkowski, Piotr
    Sciot, Raf
    De, Ivo Wever
    Ruka, Wlodzimierz
    Schoffski, Patrick
    Debiec-Rychter, Maria
    Vandenberghe, Peter
    CELLULAR ONCOLOGY, 2008, 30 (03) : 280 - 281
  • [43] Nuclear KIT induces a NFKBIB-RELA-KIT autoregulatory loop in imatinib-resistant gastrointestinal stromal tumors
    Yuan-Shuo Hsueh
    Hui Hua Chang
    Yan-Shen Shan
    H. Sunny Sun
    Jonathan Alfred Fletcher
    Chien-Feng Li
    Li-Tzong Chen
    Oncogene, 2019, 38 : 6550 - 6565
  • [44] Surgical treatment of gastrointestinal stromal tumors in the imatinib (STI-571) era
    Wu, PC
    Langerman, A
    Ryan, CW
    Hart, J
    Swiger, S
    Posner, MC
    SURGERY, 2003, 134 (04) : 656 - 665
  • [45] Frequent mono-allelic loss associated with deficient PTEN expression in imatinib-resistant gastrointestinal stromal tumors
    Quattrone, Anna
    Wozniak, Agnieszka
    Dewaele, Barbara
    Floris, Giuseppe
    Vanspauwen, Vanessa
    Van Looy, Thomas
    Schoffski, Patrick
    Rutkowski, Piotr
    Sciot, Raf
    Debiec-Rychter, Maria
    MODERN PATHOLOGY, 2014, 27 (11) : 1510 - 1520
  • [46] Heat shock protein 90 inhibition in imatinib-resistant gastrointestinal stromal tumor
    Bauer, Sebastian
    Yu, Lynn K.
    Demetri, George D.
    Fletcher, Jonathan A.
    CANCER RESEARCH, 2006, 66 (18) : 9153 - 9161
  • [47] Cas-L was overexpressed in imatinib-resistant gastrointestinal stromal tumor cells
    Thao, Le Ba
    Vu, Hoang Anh
    Yasuda, Kazuki
    Taniguchi, Shigeki
    Yagasaki, Fumiharu
    Taguchi, Takahiro
    Watanabe, Toshiki
    Sato, Yuko
    CANCER BIOLOGY & THERAPY, 2009, 8 (08) : 683 - 688
  • [48] Sunitinib in patients with imatinib-resistant gastrointestinal stromal tumor: A single center experience
    Sahu, A.
    Godbole, S.
    Jain, P.
    Ghosh, J.
    Shrikhande, S.
    Ramadwar, M.
    Goyal, M.
    Gulia, S.
    Bajpai, J.
    Kembhavi, Y.
    Gupta, S.
    INDIAN JOURNAL OF CANCER, 2015, 52 (03) : 320 - U91
  • [49] Nuclear KIT induces a NFKBIB-RELA-KIT autoregulatory loop in imatinib-resistant gastrointestinal stromal tumors
    Hsueh, Yuan-Shuo
    Chang, Hui Hua
    Shan, Yan-Shen
    Sun, H. Sunny
    Fletcher, Jonathan Alfred
    Li, Chien-Feng
    Chen, Li-Tzong
    ONCOGENE, 2019, 38 (38) : 6550 - 6565
  • [50] Pharmacokinetics of escalated dose of imatinib in patients with advanced gastrointestinal stromal tumors.
    Yoo, Changhoon
    Ryu, Min-Hee
    Ryoo, Baek-Yeol
    Park, Inkeun
    Beck, Mo Youl
    Kang, Yoon-Koo
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345